What is the recommended diagnostic workup and first-line treatment for eosinophilic gastroenteritis?

Eosinophilic Gastroenteritis: Diagnostic Workup and First-Line Treatment

For eosinophilic gastroenteritis (EGE), perform upper endoscopy with at least 6 biopsies from multiple GI sites to confirm ≥15 eosinophils per high-power field, then initiate corticosteroids as first-line treatment while excluding secondary causes of eosinophilia.

Important Distinction: EGE vs. Eosinophilic Esophagitis

The provided guidelines 1 primarily address eosinophilic esophagitis (EoE), not eosinophilic gastroenteritis. While related, these are distinct entities. EGE involves the stomach and small intestine, whereas EoE is limited to the esophagus. The diagnostic and treatment principles overlap but have key differences.

Diagnostic Workup for EGE

Clinical Presentation to Recognize

Symptoms vary by layer of GI wall involved 2, 3:

• Mucosal pattern (most common): Abdominal pain, diarrhea, nausea, vomiting, protein-losing enteropathy
• Muscular pattern: Bowel obstruction, perforation symptoms
• Serosal pattern: Ascites (particularly in young patients - a rare but classic presentation)

Key clinical clues 4, 5:

• Coexisting atopic diseases (asthma, allergic rhinitis, eczema)
• Peripheral blood eosinophilia
• Unexplained GI symptoms refractory to standard therapy
• Young to middle-aged adults (though can occur at any age)

Endoscopic Evaluation

Perform upper endoscopy with extensive biopsies 3, 6:

• Obtain biopsies from stomach and duodenum (multiple sites)
• Take at least 6 biopsies from different anatomical locations
• Endoscopic findings may be nonspecific or normal
• Look for mucosal nodularity, erythema, or thickened folds

Histopathologic Criteria

Diagnostic threshold 6:

• ≥30 eosinophils/HPF in five separate HPF is the proposed criterion for "histologic eosinophilic gastritis"
• However, this threshold may miss clinically significant cases - any prominent eosinophilic infiltration with compatible symptoms warrants consideration
• Look for additional features: basal cell hyperplasia, eosinophil microabscesses, eosinophil degranulation, subepithelial sclerosis

Mandatory Exclusion of Secondary Causes

Before diagnosing EGE, rule out 4, 7, 3:

• Parasitic infections (especially Strongyloides)
• Helicobacter pylori gastritis
• Inflammatory bowel disease (Crohn's disease)
• Hypereosinophilic syndrome
• Systemic mastocytosis
• Malignancy
• Drug reactions
• Autoimmune conditions (collagenous gastritis, autoimmune atrophic gastritis)

Additional Workup

• Complete blood count: Check for peripheral eosinophilia
• Stool examination: Rule out parasites
• IgE levels: May be elevated but not diagnostic
• Imaging (CT/MRI): Consider if muscular or serosal involvement suspected (bowel wall thickening, ascites)

Important caveat: Allergy testing (skin prick, specific IgE, patch testing) is not recommended for guiding dietary therapy 1.

First-Line Treatment

Corticosteroids: The Mainstay

Corticosteroids remain the first-line pharmacologic treatment for EGE 2, 7, 3:

• Dramatic therapeutic efficacy in most cases
• Typical regimen: Oral prednisone 20-40 mg daily (or equivalent)
• Duration: 2-4 weeks initially, then taper based on response
• 70% of patients respond to steroid-based therapy 6

Monitor response 4:

• Clinical improvement typically occurs within days to weeks
• Consider repeat endoscopy with biopsies to confirm histologic response
• Some patients require maintenance therapy to prevent relapse

Dietary Therapy as Alternative First-Line

Elimination diets can be considered before or alongside pharmacologic treatment 1, 3:

• Avoid identified food allergens if known
• Six-food elimination diet (milk, wheat, egg, soy, nuts, seafood) has highest efficacy but lowest compliance
• Requires experienced dietitian support throughout elimination and reintroduction 1
• More practical in motivated patients willing to undergo multiple endoscopies for food reintroduction

Treatment Algorithm

1. Mild to moderate symptoms: Consider trial of dietary elimination OR initiate corticosteroids
2. Severe symptoms (obstruction, severe pain, ascites): Start corticosteroids immediately
3. Assess response at 2-4 weeks: Clinical improvement and consider repeat endoscopy
4. If responsive: Taper steroids gradually; consider maintenance therapy if relapse occurs
5. If non-responsive (30% of cases): Consider higher steroid doses, combination therapy, or biologics

Critical Pitfalls to Avoid

• Don't miss secondary causes: Always exclude parasites, H. pylori, IBD, and systemic diseases before diagnosing primary EGE
• Don't rely on endoscopic appearance alone: Endoscopy may be normal; histology is essential
• Don't undertake dietary therapy without dietitian support: High failure rate without proper guidance 1
• Don't assume symptom improvement equals histologic remission: Symptoms may not correlate with ongoing eosinophilic inflammation 1
• Don't use the rigid "≥30 eosinophils/HPF" threshold exclusively: This can miss clinically significant disease 6

Refractory or Relapsing Disease

For steroid-dependent or refractory cases 7, 3:

• Consider maintenance corticosteroids at lowest effective dose
• Emerging biologics (dupilumab, anti-IL-5 agents) show promise but remain investigational for EGE
• Avoid surgery unless absolutely necessary (complications, perforation)
• Immunomodulators (azathioprine, 6-MP) have limited evidence in EGE

Follow-Up Strategy

• Regular clinic visits to monitor symptoms and treatment adherence
• Repeat endoscopy if symptoms recur on treatment 1
• Long-term monitoring for complications (strictures, malnutrition)
• 2-3% of patients develop steroid-dependent relapsing disease requiring ongoing management 6